Enhanced antibacterial effect against Enterococcus faecalis by silver ions plus Triton X-100 with low concentrations and cytotoxicity.

Enhanced antibacterial effect against Enterococcus faecalis by silver ions plus Triton X-100 with low concentrations and cytotoxicity.
复制标题

银离子加低浓度的 Triton X-100 增强对粪肠球菌的抗菌作用,并具有细胞毒性。

DOI:
10.1007/s42770-021-00643-8
复制
发表时间:
2021
期刊:
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]
影响因子:
--
通讯作者:
Wei Fan
Wei Fan
中科院分区:
其他
文献类型:
--
作者:
Qing Sun;Mengting Duan;Bing Fan;Wei Fan

文献摘要

相似文献

粪肠球菌(E. faecalis)通常被认为是继发性和持续性根管感染的罪魁祸首之一。由于抗生素耐药性已成为全球性问题,为了减少抗生素的使用,金属离子最近被广泛使用作为替代品。银离子(Ag+)已被证明是一种强杀菌剂,但具有高细胞毒性和变色性。 Triton X-100(TX-100)与Ag+首次联合用作临床根管内药物,获得增强的抗菌作用和低细胞毒性。 TX-100 + Ag+ 对牙本质上的浮游菌和生物膜粪肠球菌的协同抗菌作用进行了测试。并在MC3T3-E1细胞上测试细胞毒性。结果证实,加入 TX-100 后,对浮游和生物膜驻留粪肠球菌的抗菌活性显着提高。 TX-100 和 Ag+ 混合物表现出与 2% 氯己定 (CHX) 相似的抑制作用,而细胞毒性远低于 2% CHX (p < 0.05)。总之,TX-100+Ag+混合物可能被开发成一种新的有效的根管内药物,如2%CHX。
Enterococcus faecalis (E. faecalis) is commonly considered to be one of chief culprits of secondary and persistent root canal infections. As antibiotic resistance has become a global issue, in order to reduce the use of antibiotics, metal ions have recently been widely used as an alternative. Silver ions (Ag+) have been proved to be a strong bactericide but with high cytotoxicity and discoloration property. Triton X-100 (TX-100) and Ag+ were co-used for the first time as a clinical intracanal medication to obtain both enhanced antibacterial effect and low cytotoxicity. The synergistic antibacterial effect of TX-100 + Ag+ was tested on both planktonic and biofilm-resident E. faecalis on dentine. And the cytotoxicity was tested on MC3T3-E1 cells. Results confirmed the antibacterial activity against both planktonic and biofilm-resident E. faecalis was dramatically improved after TX-100 incorporation. TX-100 and Ag+ mixture demonstrated a similar inhibitory effect as the 2% chlorhexidine (CHX), while the cytotoxicity was much lower than 2% CHX (p < 0.05). In conclusion, TX-100 + Ag+ mixture might be developed into a new effective intracanal medication as the 2% CHX.